Literature DB >> 1434950

Using the Gompertz-Strehler model of aging and mortality to explain mortality trends in industrialized countries.

J E Riggs1, R J Millecchia.   

Abstract

Mortality trends in industrialized countries are characterized by declines in vascular disease (ischemic heart disease and stroke) and rises in cancers and degenerative diseases. These trends are typically analyzed by examining each disorder in isolation using the perspective of genetic and environmental influences. However, longitudinal Gompertzian analysis and the Gompertz-Strehler model of aging and mortality as modified by Lestienne suggest that age-specific mortality rates, for both general and disease-specific mortality, are an interrelated deterministic function of aggregate genetic, environmental and competitive influences. Consequently, evolving mortality trends and patterns appear to be influenced by three factors (with deterministic competition being the third factor), rather than just two factors (genetic and environmental) as commonly depicted.

Entities:  

Mesh:

Year:  1992        PMID: 1434950     DOI: 10.1016/0047-6374(92)90037-e

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  4 in total

1.  How genes influence life span: the biodemography of human survival.

Authors:  Anatoliy I Yashin; Deqing Wu; Konstantin G Arbeev; Eric Stallard; Kenneth C Land; Svetlana V Ukraintseva
Journal:  Rejuvenation Res       Date:  2012-05-18       Impact factor: 4.663

2.  Heterogeneity in the Strehler-Mildvan general theory of mortality and aging.

Authors:  Hui Zheng; Yang Yang; Kenneth C Land
Journal:  Demography       Date:  2011-02

3.  The Strehler-Mildvan correlation from the perspective of a two-process vitality model.

Authors:  Ting Li; James J Anderson
Journal:  Popul Stud (Camb)       Date:  2015-01-30

4.  Onset of mortality increase with age and age trajectories of mortality from all diseases in the four Nordic countries.

Authors:  Josef Dolejs; Petra Marešová
Journal:  Clin Interv Aging       Date:  2017-01-21       Impact factor: 4.458

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.